Preclinical Evaluation of Efficacy and Safety of an Improved Lentiviral Vector for the Treatment of &bgr;-Thalassemia and Sickle Cell Disease

Publisher: Bentham Science Publishers

E-ISSN: 1875-5631|15|1|64-81

ISSN: 1566-5232

Source: Current Gene Therapy, Vol.15, Iss.1, 2015-02, pp. : 64-81

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content